Brief: BioArctic Says Sales Of Leqembi Totaled 1.1 Billion Yen In Q4 2023
06/02/2024 03:38
Feb 5 (Reuters) - BioArctic AB BIOAb.ST :
* SALES OF LEQEMBI® TOTALED 1.1 BILLION YEN IN Q4 2023
* IN TOTAL, SALES OF JPY 1.1 BILLION WERE RECORDED IN Q4,
RESULTING IN A ROYALTY TO BIOARCTIC AMOUNTING TO SEK 7.3 MILLION
Source text for Eikon: ID:nWkr2tGb85
Further company coverage: BIOAb.ST
((reuters.briefs@thomsonreuters.com;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln